HomeCDTX • NASDAQ
add
Cidara Therapeutics Inc
Previous close
$21.04
Day range
$21.48 - $25.58
Year range
$10.14 - $28.42
Market cap
330.73M USD
Avg Volume
144.15K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 24.82M | 167.22% |
Net income | -23.48M | -127.39% |
Net profit margin | — | — |
Earnings per share | -1.66 | 27.19% |
EBITDA | -25.23M | -196.65% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 168.15M | 479.47% |
Total assets | 191.73M | 263.70% |
Total liabilities | 50.04M | -29.01% |
Total equity | 141.68M | — |
Shares outstanding | 12.97M | — |
Price to book | 1.81 | — |
Return on assets | -31.08% | — |
Return on capital | -40.59% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -23.48M | -127.39% |
Cash from operations | -21.95M | -230.37% |
Cash from investing | 185.00K | 904.35% |
Cash from financing | 77.00K | 182.80% |
Net change in cash | -21.69M | -220.83% |
Free cash flow | -14.33M | -3,254.46% |
About
Founded
2012
Headquarters
Website
Employees
38
